About this information
Search the summaries of completed Access to Information (ATI) requests to find information about ATI requests made to the Government of Canada after January 2020. If you find a summary of interest, you can request a copy of the records at no cost using the form below each summary. Requests made through this form are considered informal requests and are not subject to the same requirements as requests under the Access to Information Act (ATIA).
If you don’t find what you are looking for you can request additional government records under an institution’s control by contacting the institution’s Access to Information and Privacy Coordinator or by submitting a formal access to information request.
*All information provided will incorporate the necessary exemptions and exclusions as per the Access to Information Act and the Privacy Act.
Download datasets of the summaries of completed access to information requests.
Current Search
Report Type
Organization
Disposition
Year
Month
Found 83 record(s)
Req # A-2020-001725
Documents related to Dominique Baker’s managerial position held during the month of November 2020 - Job title; detailed job description, on the appropriate Federal government form which would be on file at Public Health Agency of Canada (PHAC) and salary range.Organization: Health Canada
April 2021
Req # A-2020-001898
From January 1 2010 to March 25, 2021, a report for all New Drug Submissions (NDS) with the current status of “cleared” that contains the date that the submission was approved, sponsor name, and brand name of the drug.Organization: Health Canada
April 2021
Req # A-2020-000813
Adverse Drug Reaction (ADR) for Botulinum toxin indication/injection site. Report number: E2B_03170851.Organization: Health Canada
April 2021
Req # A-2020-000879
Briefing note in the Ministerial Executive Correspondence System (MECS) for the following file: 20-106577-364, Deputy Ministerial meeting with Genome Canada.Organization: Health Canada
April 2021
Req # A-2020-001008
Adverse Drug Reaction (ADR) for DOCETAXEL. Report number: E2B_02874464.Organization: Health Canada
April 2021
Req # A-2020-001233
Adverse Drug Reaction (ADR) for Pheburane® (Sodium Phenylbutyrate). Report number: E2B_03075820.Organization: Health Canada
April 2021
Req # A-2020-001321
Briefing note in the Ministerial Executive Correspondence System (MECS) for the following file: 20-075336-232, Canadian Human Rights Commission’s Horizontal Audit on Employment of Racialized People in Executive and Management Positions in the Public Sector.Organization: Health Canada
April 2021
Req # A-2020-001357
Briefing note in the Ministerial Executive Correspondence System (MECS) for the following file: 20-113937-85, Results of Health Canada’s application to Mediacorp’s 2021 Top 100 Employers Competition.Organization: Health Canada
April 2021
Req # A-2020-001441
Adverse Reaction Reports (AERs) for ANTI-THYMOCYTE GLOBULIN (RABBIT). Report numbers: E2B_03058764, E2B_03058773, E2B_03058779, E2B_03062549, E2B_03062567, E2B_03062578, E2B_03062587, E2B_03062592, E2B_03064020, E2B_03064028, E2B_03064032, E2B_03064035, E2B_03064036, E2B_03064052, E2B_03064461.Organization: Health Canada
April 2021
Req # A-2020-001470
Briefing note in the Ministerial Executive Correspondence System (MECS) for the following file: 19-123456-504, 2020 Association of Professional Executives of the Public Service - Awards of Excellence.Organization: Health Canada
April 2021